Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast Calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Parenteral nutrition industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Composition trends
2.1.4 Type trends
2.1.5 Consumer trends
2.1.6 End-user trends
Chapter 3 Parenteral Nutrition Market Insights
3.1 Industry ecosystem
3.2 Industry landscape, 2018 – 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing metabolic disorders and other chronic diseases
3.3.1.2 Growing malnutrition across the globe
3.3.1.3 Rising geriatric population
3.3.1.4 Increasing rate of pre-mature birth & birth rate
3.3.1.5 Growing adoption of home healthcare settings in developed countries
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of clinical evidence to support novel technology
3.3.2.2 Lack of awareness in developing countries
3.4 Growth potential analysis
3.4.1 By composition
3.4.2 By type
3.4.3 By consumer
3.4.4 By end-user
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 China
3.6.3 India
3.6.4 Europe
3.6.4.1 Germany
3.6.4.2 UK
3.6.4.3 France
3.6.4.4 Italy
3.6.4.5 Spain
3.7 Innovation outlook
3.7.1 Innovation landscape
3.7.2 Technology evolution
3.7.3 Future innovation outlook of the market
3.7.4 Initiatives undertaken/proposed by key companies
3.8 Value chain analysis
3.9 Pricing analysis
3.9.1 By region
3.9.2 By country
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Fresenius Kabi AG
4.1.2 Baxter International, Inc
4.1.3 B Braun Melsungen AG
4.2 Company matrix analysis
4.3 Company positioning matrix, 2022
4.4 Company market share analysis, 2022
4.4.1 Global
4.4.1.1 Global RTU/Standard commercial parenteral nutrition
4.4.1.2 Global Single nutriments market share analysis, 2022
4.4.1.3 Global 2/3 chamber bags market share analysis, 2022
4.4.1.4 Global compounded parenteral nutrition market share analysis, 2022
4.4.2 U.S.
4.4.2.1 U.S. RTU/Standard commercial parenteral nutrition
4.4.2.2 U.S. compounded parenteral nutrition market share analysis, 2022
4.4.3 China
4.4.3.1 China RTU/Standard commercial parenteral nutrition
4.4.3.2 China compounded parenteral nutrition market share analysis, 2022
4.4.4 India
4.4.5 Germany
4.4.6 France
4.4.7 UK
4.4.8 Italy
4.4.9 Spain
4.5 Competitive analysis of major market players
4.6 Strategy dashboard
Chapter 5 Parenteral Nutrition Market Estimates and Forecast, By Composition, 2018-2032 (USD Million)
5.1 Key trends, by composition
5.2 Amino acids
5.3 Fats
5.4 Carbohydrates
5.5 Trace elements
5.6 Vitamins
5.7 Minerals
5.8 Other compositions
Chapter 6 Parenteral Nutrition Market Estimates and Forecast, By Type, 2018-2032 (USD Million)
6.1 Key trends, by type
6.2 RTU/standard commercial parenteral nutrition
6.2.1 Single nutriment
6.2.2 RTU 2or 3 chamber bags
6.3 Compounded parenteral nutrition
6.3.1 Monobags/mixing bags
6.3.2 2 or 3 chamber bags
Chapter 7 Parenteral Nutrition Market Estimates and Forecast, By Consumer, 2018-2032 (USD Million)
7.1 Key trends, by consumer
7.2 Newborn & children
7.3 Adults
Chapter 8 Parenteral Nutrition Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)
8.1 Key trends, by end user
8.2 Hospitals
8.3 Clinics
8.4 Homecare settings
8.5 Other End-users
Chapter 9 Parenteral Nutrition Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 B. Braun Melsungen AG
10.2 Baxter International, Inc.
10.3 Fresenius Kabi AG
10.4 OTSUKA HOLDINGS CO., LTD
10.5 Amanta Healthcare
10.6 Grifols International S.A.
10.7 ICU Medical
10.8 Aculife Healthcare
10.9 AbbVie, Inc
10.10 Sichuan Kelun Pharmaceutical Co. Ltd.
10.11 Aguettant
10.12 Xi’an Libang Enterprises
10.13 Anhui Medipharm Co., Ltd.
